STOCK TITAN

ACM Research (ACMR) CFO exercises options, sells 55K shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ACM Research, Inc. (ACMR) reported that Chief Financial Officer and Treasurer Mark McKechnie exercised stock options for a total of 55,199 shares of Class A Common Stock on August 20, 2026, at exercise prices of $19.49 and $13.89 per share, from fully vested options. He then sold 55,199 shares in three transactions at weighted-average prices of $76.34, $77.45, and $77.89 per share, with the sales effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2026.

Positive

  • None.

Negative

  • None.
Insider McKechnie Mark
Role See Remarks
Sold 55,199 shs ($4.26M)
Approx. gross sale proceeds $4.26M
Approx. exercise cost $936K
Approx. pre-tax spread $3.33M
Type Security Shares Price Value
Exercise Stock Option F5 30,199 $0.00 $0.00
Exercise Stock Option F5 25,000 $0.00 $0.00
Exercise Class A Common Stock 30,199 $19.49 $589K
Exercise Class A Common Stock 25,000 $13.89 $347K
Sale Class A Common Stock F1, F2 13,625 $76.34 $1.04M
Sale Class A Common Stock F1, F3 30,365 $77.45 $2.35M
Sale Class A Common Stock F1, F4 11,209 $77.89 $873K
Holdings After Transaction: Stock Option — 246,250 shares (Direct); Class A Common Stock — 900 shares (Direct)
Footnotes (5)
  1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.76 to $76.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4.
  3. F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.81 to $77.79, inclusive.
  4. F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.84 to $78.4, inclusive.
  5. F5. The option is fully vested and exercisable.
Options exercised at $19.49 30,199 shares at $19.49 per share Stock options for Class A Common Stock exercised on August 20, 2026; expiration August 11, 2032
Options exercised at $13.89 25,000 shares at $13.89 per share Stock options for Class A Common Stock exercised on August 20, 2026; expiration August 9, 2033
Total shares acquired via exercise 55,199 shares Class A Common Stock received from option exercises on August 20, 2026
Sale at weighted-average $76.34 13,625 shares at $76.34 per share Class A Common Stock sale; price is a weighted-average over $75.76–$76.68
Sale at weighted-average $77.45 30,365 shares at $77.45 per share Class A Common Stock sale; price is a weighted-average over $76.81–$77.79
Sale at weighted-average $77.89 11,209 shares at $77.89 per share Class A Common Stock sale; price is a weighted-average over $77.84–$78.40
Total shares sold 55,199 shares Aggregate Class A Common Stock sold on August 20, 2026
Rule 10b5-1 plan adoption date May 21, 2026 Date the reporting person adopted the trading plan governing the reported sales
Rule 10b5-1 trading plan regulatory
"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Class A Common Stock financial
"underlying_security_title: "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
fully vested and exercisable financial
"The option is fully vested and exercisable."

FAQ

What insider transactions did ACMR’s CFO report on August 20, 2026?

ACMR’s CFO Mark McKechnie exercised options for 55,199 shares of Class A Common Stock and sold 55,199 shares on August 20, 2026. The options had exercise prices of $19.49 and $13.89 per share.

At what prices did the ACMR CFO sell shares in this Form 4 filing?

Mark McKechnie reported selling ACMR Class A Common Stock at weighted-average prices of $76.34, $77.45, and $77.89 per share. Footnotes state each price reflects multiple transactions within disclosed price ranges.

Were the ACMR CFO’s August 20, 2026 share sales under a Rule 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026, and the Rule 10b5-1 checkbox is marked true.

What option grants did the ACMR CFO exercise in this Form 4?

He exercised fully vested stock options covering 30,199 shares at an exercise price of $19.49 per share (expiring August 11, 2032) and 25,000 shares at an exercise price of $13.89 per share (expiring August 9, 2033).

How many ACMR shares did the CFO sell in total on August 20, 2026?

He sold a total of 55,199 shares of ACM Research Class A Common Stock, in three sales of 13,625, 30,365, and 11,209 shares, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
McKechnie Mark

(Last)(First)(Middle)
C/O ACM RESEARCH, INC.
42307 OSGOOD ROAD, SUITE I

(Street)
FREMONT CALIFORNIA 94539

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ACM Research, Inc. [ ACMR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See Remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/20/2026M30,199A$19.4931,099D
Class A Common Stock08/20/2026M25,000A$13.8956,099D
Class A Common Stock08/20/2026S(1)13,625D$76.34(2)42,474D
Class A Common Stock08/20/2026S(1)30,365D$77.45(3)12,109D
Class A Common Stock08/20/2026S(1)11,209D$77.89(4)900D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$19.4908/20/2026M30,199 (5)08/11/2032Class A Common Stock30,199$031,250D
Stock Option$13.8908/20/2026M25,000 (5)08/09/2033Class A Common Stock25,000$0215,000D
Explanation of Responses:
1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2026.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.76 to $76.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), and (4) to this Form 4.
3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.81 to $77.79, inclusive.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.84 to $78.4, inclusive.
5. The option is fully vested and exercisable.
Remarks:
Chief Financial Officer and Treasurer
/s/ Mark McKechnie08/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)